/Companies

Eton Pharmaceuticals

NASDAQ: ETON

San Diego, US · Founded 2017 · Delaware corporation · 59 employees on LinkedIn

Find your way into Eton Pharmaceuticals

Sign up to see every warm intro you have to Eton Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Eton Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products, including injectable and rare disease treatments. Its leadership team has experience across pharmaceutical product development, commercialization, quality/GxP compliance, and finance.

Founders & leadership

Eton Pharmaceuticals was founded in 2017 by Sean E. Brynjelsen.

SE
Sean E. BrynjelsenFounder · CEOSean E. Brynjelsen is President and CEO of Eton Pharmaceuticals, a specialty pharmaceutical company developing injectable and rare disease treatments. He holds a degree from the University of Notre Dame's Mendoza College of Business and has experience in pharmaceutical R&D, FDA regulatory affairs, medical devices, and oncology.
JMJudy Matthews
Judy MatthewsChief Financial Officer
JRJames R. Gruber
James R. GruberChief Financial Officer2022–2026James R. Gruber is Chief Financial Officer, Treasurer, and Secretary at Eton Pharmaceuticals. He brings over 25 years of life sciences finance experience, including leadership roles managing financial organizations and capital allocation across healthcare, manufacturing, and distribution sectors, with an MBA from Northwestern University's Kellogg School of Management and a B.S. in Accounting from Indiana University.
DCDavid C. Krempa
David C. KrempaChief Business Officer
IEIpek Erdogan-Trinkaus
Ipek Erdogan-TrinkausChief Commercial Officer (CCO)Ipek Erdogan-Trinkaus has held commercial and leadership roles across pharmaceutical and nutrition companies, ranging from Fortune 100 organizations to startups, with expertise in brand building, strategy development, and team leadership.
MB
Mark BaumFounder & Boardmember2017–2021Executive Officer at Harrow Health
AB
Andrew BollNamed on SEC filing

Board

CC
Charles CasamentoBoard director

Reported raises · per SEC filings

Form D private placements

$27.6M disclosed across 2 rounds · 2017–2020

▶$7.5MraisedApr 2020 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark L BaumDirector
  • William Wilson TroutmanExecutive Officer
  • Sean BrynjelsenExecutive Officer, Director
  • Charles J CasamentoDirector
  • Paul V MaierDirector
  • Norbert G RiedelDirector
Offering amount
$7.5M
Amount sold
$7.5M
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.1MraisedJun 2017 · 230 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles CasamentoDirector
  • Mark BaumDirector
  • Andrew BollDirector
  • Sean BrynjelsenExecutive Officer, Director
Offering amount
$20.1M
Amount sold
$20.1M
Sales commissions
$2M
Placement agents
National Securities Corporation
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$101.5Mvaluation at IPONov 2018 · $6.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Founder mafia

2 people who came through Eton Pharmaceuticals went on to found or lead other companies.

Related companies · 3

Companies working in the same space as Eton Pharmaceuticals.

In the news

Frequently asked questions

What does Eton Pharmaceuticals do?
Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products, including injectable and rare disease treatments. Its leadership team has experience across pharmaceutical product development, commercialization, quality/GxP compliance, and finance.
Who founded Eton Pharmaceuticals?
Eton Pharmaceuticals was founded by Sean E. Brynjelsen in 2017.
How much funding has Eton Pharmaceuticals raised?
Eton Pharmaceuticals has disclosed $27.6M raised across 2 rounds.
Where is Eton Pharmaceuticals headquartered?
Eton Pharmaceuticals is headquartered in San Diego, US.